2024年二季度新兴技术指标（英）2024

Q2 2024 Emerging Tech Indicator Summary

Introduction

The Emerging Tech Indicator (ETI) provides a quarterly review of angel, seed, and early-stage investment activity involving a limited subset of the world’s most successful VC firms, representing roughly 10% of total VC investment. The analysis highlights the types of technologies viewed as most promising by top investors and tracks their capital allocation decisions.

Key Takeaways

1. Deal Activity:

   • Total Investment: Q2 2024 saw a significant rise in deal activity, with $11.9 billion invested across 168 deals. Excluding the two largest rounds of $6.0 billion and $1.0 billion, Q2 2024 was the strongest quarter since Q3 2022.
   • Median Deal Size: The median deal size for the angel & seed stages increased to $5.0 million, while early-stage deals rose to approximately $20.0 million.

2. Top Categories of Investment:

   • AI & Machine Learning (AI & ML): Captured $8.4 billion across 40 deals.
   • Biotech: Raised $1.6 billion across five deals.
   • Fintech: Secured $308.4 million across 19 deals.
   • Information Security (Infosec): Attracted $290.1 million across 12 deals.
   • Health & Wellness Tech: Received $230.8 million across 14 deals.
   • Web3 & DeFi: Experienced a decline, with $220.1 million invested across 10 deals, down from $294.7 million in the previous quarter.

3. Large Deals:

   • Top Three Deals:
     • $6.0 billion Series B for xAI (Elon Musk’s AI platform).
     • $1.0 billion Series A for Xaira Therapeutics (AI-driven drug discovery platform).
     • $650.6 million Series B for Mistral AI (France-based AI foundation model provider).

4. Deal Activity Trends:

   • ETI Deal Activity by Quarter: The chart shows a steady increase in deal activity since the end of 2023, suggesting a potential resurgence in dealmaking.
   • Cumulative Four-Quarter Basis: AI & ML, biotech, and fintech continued to dominate ETI capital.

Areas of Investment

• AI & Machine Learning (AI & ML): Largest area of investment, with $8.4 billion across 40 deals.
• Biotech: Raised $1.6 billion across five deals.
• Fintech: Secured $308.4 million across 19 deals.
• Information Security (Infosec): Attracted $290.1 million across 12 deals.
• Health & Wellness Tech: Received $230.8 million across 14 deals.
• Web3 & DeFi: Declined slightly to $220.1 million across 10 deals.

Conclusion

While there is a broad decline in ETI activity since its peak in Q2 2022, the steady rise since late 2023 suggests a potential resurgence. Large deals and the increasing number of high-value transactions indicate ongoing interest from investors in these sectors.